Point Pleasant, NJ, United States of America

Douglas A Higgins


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2013-2019

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Douglas A. Higgins

Introduction

Douglas A. Higgins is an accomplished inventor based in Point Pleasant, NJ (US). He holds 2 patents that reflect his significant contributions to the field of biotechnology. His work primarily focuses on genetically modifying microorganisms and understanding bacterial pathogenicity.

Latest Patents

Higgins' latest patents include "Engineered microorganisms having resistance to ionic liquids" and "Identification of bacterial autoinducer and use in treating bacterial pathogenicity." The first patent provides a method for genetically modifying microorganisms to enhance their resistance to ionic liquids. This involves using specific polypeptides and host cells that have been genetically modified to improve their performance in reactions involving biomass pretreated with ionic liquids. The second patent details the purification and structural identification of a bacterial autoinducer, CAI-1, along with methods for synthesizing the autoinducer and its analogues. This invention also describes strategies for treating bacterial pathogenicity and biofilm formation, including methods for preventing and treating cholera.

Career Highlights

Throughout his career, Higgins has worked with notable organizations such as Lawrence Livermore National Security, LLC and Princeton University. His experience in these institutions has allowed him to develop and refine his innovative ideas in the field of microbiology and biotechnology.

Collaborations

Higgins has collaborated with esteemed colleagues, including Michael P. Thelen and Thomas L. Ruegg. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Douglas A. Higgins is a notable inventor whose work in genetic modification and bacterial pathogenicity has made significant strides in biotechnology. His patents and collaborations reflect his dedication to innovation and the advancement of scientific knowledge.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…